19.10.2009 12:28:00

IntegraMed® Announces New Attain™ IVF Multi-Cycle In Vitro Fertilization Treatment Financing Program

IntegraMed America, Inc. (NASDAQ: INMD), the nation’s leading manager of specialty outpatient healthcare facilities in the emerging, technology-focused medical niches of fertility and vein care, today announced that it has expanded its Attain™ IVF (In Vitro Fertilization) family of treatment financing offerings to include the Attain IVF Multi-Cycle Program.

The new Attain IVF Multi-Cycle Program was developed for patients who are seeking a lower cost option to enter IVF treatment and provides them with up to four IVF treatment cycles for one up-front discounted fee. The Attain IVF Multi-Cycle also offers expanded patient eligibility standards, enabling the enrollment of most patients who have been referred by their physician for IVF treatment, including those who were not eligible for IntegraMed’s Attain IVF Refund Program.

Pamela Schumann, President of the Consumer Services Division of IntegraMed commented, "We are very excited to further expand the array of treatment finance offerings available through the IntegraMed Fertility Network and remain committed to providing Attain IVF Program participants course-of-treatment options and customer care support that will best help them improve their chances of having children.

"The lower cost Attain IVF Multi-Cycle program meets a growing patient need for more affordable IVF treatment pricing. While not a refund program, Attain IVF Multi-Cycle does provide an affordable alternative to pay-as-you-go treatment by helping to eliminate the anxiety and worry often associated with the cost of IVF treatment.”

The Attain Multi-Cycle Program is initially being offered at the following eight IntegraMed Fertility Network practices and will be rolled out to the entire network in the next few months:

  • Atlanta Center for Reproductive Medicine
  • Center for Reproductive Medicine, Orlando
  • Cleveland Clinic
  • Dallas IVF
  • IVF Florida Reproductive Associates
  • Reproductive Endocrinology Associates of Charlotte
  • Reproductive Medicine Associates of Michigan
  • Reproductive Science Center of the San Francisco Bay Area.

Pioneered by IntegraMed on a nationwide basis, the Attain IVF programs offer several treatment financing alternatives that enable patients to better manage the financial commitment associated with undergoing a series of IVF treatments. For most IVF patients the Attain IVF programs present an opportunity to significantly increase their chances of success by providing them with the financial means to stay in treatment longer. For more information about the Attain IVF Program please visit www.attainivf.com.

About IntegraMed America, Inc.

IntegraMed America, Inc. manages highly specialized outpatient facilities in emerging, technology-based, niche medical markets and is the leading manager of fertility centers and vein clinics in the United States. IntegraMed supports its provider networks with clinical and business information systems, marketing and sales, facilities and operations management, finance and accounting, human resources, legal, risk management and quality assurance services. IntegraMed also offers treatment-financing programs for self-pay patients.

IntegraMed’s fertility network is the nations largest fertility network, comprised of 36 contracted centers with over 100 locations in 31 states and the District of Columbia. Nearly one of every four IVF procedures in the U.S. is performed in an IntegraMed network fertility practice. The IntegraMed Vein Care network is the leading provider of varicose vein care services in the US, operating 34 centers in 13 states, principally in the Midwest and Southeast.

For more information about IntegraMed please visit:

www.integramed.com for investor background,

www.integramedfertility.com for fertility, or

www.veinclinics.com for vein care

Nachrichten zu Integramed America IncShsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Integramed America IncShsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!